MALIGNANT CONNECTIVE TISSUE NEOPLASM

MALIGNANT CONNECTIVE TISSUE NEOPLASM was reported 22 times

MALIGNANT CONNECTIVE TISSUE NEOPLASM is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Provitamin D2 Compound [EPC] 1 0.0000
1 BCL-2 Inhibitor [EPC] 1 0.0000
2 Alkylating Drug [EPC] 2 0.0000
3 Microtubule Inhibitor [EPC] 1 0.0000
4 Vascular Endothelial Growth Factor Inhibitor [EPC] 1 0.0000
5 Thiazide Diuretic [EPC] 1 0.0000
6 Mood Stabilizer [EPC] 1 0.0000
7 Factor Xa Inhibitor [EPC] 1 0.0000
8 Kinase Inhibitor [EPC] 2 0.0000
9 Angiotensin 2 Receptor Blocker [EPC] 1 0.0000
10 Loop Diuretic [EPC] 1 0.0000
11 Platelet Aggregation Inhibitor [EPC] 1 0.0000
12 Corticosteroid [EPC] 2 0.0000
13 Tumor Necrosis Factor Blocker [EPC] 1 0.0000
14 Nonsteroidal Anti-inflammatory Drug [EPC] 1 0.0000